OR WAIT null SECS
Princess Ogbogu, MD, from the University of Hospitals Rainbow Babies & Children’s Hospital
November 10, 2025
Video
In a phase 3 NATRON trial presented at ACAAI 2025, Ogbogu discussed how benralizumab reduced flare in patients with hypereosinophilic syndrome.